Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge

Leuk Lymphoma. 2010 Sep;51(9):1592-5. doi: 10.3109/10428194.2010.509456.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Hepatitis B / drug therapy
  • Hepatitis B / etiology*
  • Hepatitis B virus / physiology*
  • Humans
  • Lymphoma, B-Cell / virology*
  • Prognosis
  • Rituximab
  • Survival Rate
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab